We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

O2 Consumption and Heart Rate Response to Battle Rope Exercise Protocol Versus UE Arm Bike Test in Adults With SCI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03793595
Recruitment Status : Unknown
Verified April 2021 by Wayne Brewer, Texas Woman's University.
Recruitment status was:  Recruiting
First Posted : January 4, 2019
Last Update Posted : April 19, 2021
Sponsor:
Information provided by (Responsible Party):
Wayne Brewer, Texas Woman's University

Brief Summary:
The purpose of this study is to compare energy expenditure and metabolic outcomes of a novel seated battle rope protocol to seated maximal ramped upper extremity ergometry protocol in subjects with spinal cord injury.

Condition or disease Intervention/treatment Phase
Spinal Cord Injury at T2 and Below Device: Seated Battle Ropes Protocol Device: Seated Upper Extremity Arm Bike Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Oxygen Consumption and Heart Rate Response to Battle Rope Exercise Protocol Versus Upper Extremity Arm Bike Test in Adults With Spinal Cord Injury
Actual Study Start Date : March 20, 2019
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Seated Battle Ropes Protocol Device: Seated Battle Ropes Protocol
Participants will begin swinging the rope as previously described in the seated position using the double arm swing technique for 15 seconds at a cadence of 100 beats/ minutes with a 45 second rest break repeated 10 times.

Active Comparator: Seated Upper Extremity Arm Bike Device: Seated Upper Extremity Arm Bike
A modified Young Men's Christian Association (YMCA) cycle test will be performed.




Primary Outcome Measures :
  1. Cardiorespiratory fitness as assessed by maximum oxygen uptake (VO2max) [ Time Frame: about 10-15 minutes after start of the protocol ]
    VO2max will be measured using a portable metabolic cart (Cosmed k5b).


Secondary Outcome Measures :
  1. Heart Rate [ Time Frame: about 10-15 minutes after start of the protocol ]
  2. Rate of perceived exertion as assessed by the Borg 6-20 Perceived exertion scale [ Time Frame: about 10-15 minutes after start of the protocol ]
    The Borg 6-20 Perceived exertion scale score ranges from 6-20, higher score indicates a worse outcome.

  3. Blood pressure [ Time Frame: about 10-15 minutes after start of the protocol ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Spinal cord lesion T2 or below
  • Individuals with spinal cord injury for greater than six months
  • Utilize manual wheelchair for greater than 10 hours a day

Exclusion Criteria:

  • Current complaints of spinal, lower extremity or upper extremity pain or musculoskeletal disorder that prevents the subject from performing repetitive upper extremity cycling or grasping and swinging the weighted ropes against the floor
  • A current diagnosis of a chronic or acute cardiovascular, metabolic, renal or pulmonary disease including use of a pacemaker
  • Anyone currently taking beta blocker medication
  • Anyone with blood pressure >140/90 at the time of testing or with in the 2 weeks prior to testing
  • Diagnosed sickle cell disease or sickle cell trait
  • Severe spasticity or joint contracture preventing subject from performing upper extremity cycling or swinging of weighted ropes
  • Subjects with current decubital ulcers
  • History of autonomic dysreflexia in the last 6 months
  • Require physician follow-up prior to starting exercise based on PAR-Q+ questionnaire

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03793595


Contacts
Layout table for location contacts
Contact: Wayne A Brewer, PhD 713-794-2074 wbrewer@twu.edu

Locations
Layout table for location information
United States, Texas
Texas Woman's University Recruiting
Houston, Texas, United States, 77030
Contact: Wayne A Brewer, PhD    713-794-2074    wbrewer@twu.edu   
Principal Investigator: Wayne Brewer, PhD, MPH         
Sponsors and Collaborators
Texas Woman's University
Investigators
Layout table for investigator information
Principal Investigator: Wayne A Brewer, PhD Texas Woman's University
Layout table for additonal information
Responsible Party: Wayne Brewer, Associate Professor, Texas Woman's University
ClinicalTrials.gov Identifier: NCT03793595    
Other Study ID Numbers: IRB-FY2019-34
First Posted: January 4, 2019    Key Record Dates
Last Update Posted: April 19, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries